WGS Price Prediction Next Week
Analysis and Insights
Technical Analysis:
The stock price of WGS is currently trading below its Fibonacci pivot point of 95.38, indicating bearish momentum. The Relative Strength Index (RSI) of 49.71 suggests the stock is near neutral territory, but the Stochastic Oscillator readings of 37.81 indicate oversold conditions. The MACD is positive but showing signs of weakness, with the signal line close to crossing below the MACD line.
Fibonacci Levels:
The Fibonacci levels indicate key resistance and support levels. The stock is currently below the pivot point of 95.38, with the next resistance level at 102.81 and support at 87.95.
{FIBONACCI:symbol=WGS.O, type=0}
Insider and Institutional Sentiment:
Recent insider activity shows significant sales by both the CEO and CFO, with no purchases over the past six months. This could indicate a lack of confidence in short-term appreciation. However, institutional investors have shown mixed sentiment, with 140 increasing their positions and 56 decreasing theirs.
Price Prediction:
Based on the technical indicators and insider activity, the stock is expected to face resistance at the 95-100 range. If it fails to break above this level, it may drop to the lower Fibonacci support levels. The predicted price for the next trading week is $85-$87.
Recommendation:
Given the current technical setup and insider activity, it is recommended to sell WGS stock as the price is expected to decline in the short term.
WGS Similar Chart Price Prediction
The price of WGS is predicted to go up 12.5%, based on the high correlation periods with TNDM. The similarity of these two price pattern on the periods is 97.36%.
WGS
TNDM
Up: 12.5%Similarity: 97.36%
WGS Revenue Forecast
WGS EPS Forecast
WGS FAQs
What is WGS revenue forecast for next quarter？
What is WGS eps forecast for next quarter？
WGS Analyst's Forecast
Dan Brennan
TD Cowen
Strong Buy
2025-01-07
Price Target
$75 → $118
Upside
+21.6%
TD Cowen raised the firm's price target on GeneDx to $118 from $75 and keeps a Buy rating on the shares. The firm reviewed its financial model following the stock's rise and believes there is room for upside noting its published trial studies support its strong competitive position.
Brandon Couillard
Wells Fargo
Hold
2024-10-30
Price Target
$34 → $75
Downside
-9.86%
Bill Bonello
Craig-Hallum
Strong Buy
2024-10-30
Price Target
$70 → $95
Upside
+14.18%
